BioTechX Europe

A three-day congress in Basel positioned as Europe's largest event covering data, AI and genomics in pharma and healthcare, where research and development data teams from the major pharmaceutical companies work through drug-discovery AI, bioinformatics, real-world evidence and clinical machine learning.

DATES
6–8 October 2026
VENUE
Messe Basel
ORGANISER
Terrapinn Holdings Ltd
ATTENDANCE
~3,000 (organiser figure)

Definition

BioTechX Europe is an annual congress held at Messe Basel, dedicated to the application of data, artificial intelligence and genomics across pharmaceutical research and development. The programme runs technical tracks covering AI in drug discovery, large language models in pharma, bioinformatics, real-world evidence, AI in clinical trials and multi-omics, drawing roughly 3,000 participants, around 400 speakers and 150 exhibitors. It is organised by Terrapinn and sits deliberately at the intersection of computational science and pharmaceutical R&D rather than clinical medicine or commercial deal-making.

What BioTechX Europe covers and who it is for

BioTechX addresses the data and AI layer inside pharmaceutical research, the part of the value chain where drug discovery, clinical development and genomics meet machine learning. It is built for the people who do that work and the executives who sponsor it: R&D data scientists, bioinformaticians, AI and machine-learning engineers, genomics specialists and the chief data and digital officers above them. The science on stage is computational and infrastructural, covering model architectures, data integration and laboratory automation, rather than clinical outcomes, which sets it apart from both medical congresses and digital health investor forums.

Who attends BioTechX Europe

What BioTechX Europe covers programmatically

The programme is organised across hubs and thematic tracks:

Programme tracks and special formats

The congress is structured around themed hubs, including a Healthcare 4.0 Hub, a Discovery Disrupted Hub and a Data Unleashed Hub, alongside roundtables and an exhibition of data and AI vendors serving the sector.

Notable speakers

Speakers are drawn mainly from the data and AI functions of the major pharmaceutical companies:

FAQ · Identity and audience

Is BioTechX a clinical or a technical event?

Technical. The programme is built around data science, AI and genomics in pharmaceutical R&D, with sessions on model architectures, bioinformatics and laboratory automation. Clinicians attend, but the centre of gravity is computational rather than clinical practice.

How does it differ from MEDICA or HLTH Europe?

MEDICA is a broad medical-device and diagnostics trade fair; HLTH Europe targets digital health executives, payers and investors. BioTechX is narrower and deeper, aimed at the R&D data teams inside pharma and their chief data officers, with hands-on tracks in bioinformatics, cheminformatics and large language models that neither of the others runs at this depth.

Who is BioTechX NOT designed for?
  • Medical device manufacturers seeking a hardware sourcing floor
  • Commercial and market-access functions without an R&D data remit
  • Clinicians attending for continuing medical education
  • Generalist AI professionals with no life-sciences connection
  • Teams focused on consumer digital health or wellness products

The venue: Messe Basel

BioTechX Europe is held at Messe Basel (MCH Messe Basel), in the centre of the Swiss pharmaceutical hub. Basel hosts the headquarters of several major pharmaceutical companies, which reinforces the event's positioning as a regional meeting point for pharma R&D and data teams.

The organiser: Terrapinn Holdings Ltd

Terrapinn is a global business-to-business event company specialising in life sciences, financial services and technology, headquartered in the United Kingdom. It runs the BioTechX congresses in Europe and the United States and operates a portfolio of life-sciences and technology events. BioTechX evolved from the earlier BioData World Congress, rebranding to its current name in 2022.

Editorial take

BioTechX Europe is the technical meeting point for data and AI practitioners inside pharma: not a deal-making congress but a working forum where R&D data teams from Novartis, Roche and their peers argue out drug-discovery AI, bioinformatics and genomics across three days in Basel.

How to register and what it costs

Registration is handled through the official Terrapinn event page. Conference passes start from 2,495 EUR, and free passes are available to qualifying pharmaceutical and biotechnology companies via application. The early-bird deadline for 2026 has passed as of verification.

FAQ · Access and practicalities

Where is BioTechX Europe held?

At Messe Basel (MCH Messe Basel), Messeplatz, Basel, Switzerland.

Can pharma and biotech staff attend for free?

Yes, qualifying pharmaceutical and biotechnology delegates can apply for complimentary passes; standard conference passes start from 2,495 EUR.

Is the programme more about AI or about genomics?

Both are structural. The congress self-describes as covering data, AI and genomics together, with dedicated tracks for AI in drug discovery, bioinformatics and multi-omics running in parallel.

Resources

Official website https://www.terrapinn.com/conference/biotechx/index.stm
Register https://www.terrapinn.com/conference/biotechx/index.stm
Organiser https://www.terrapinn.com